SCHEMBL4506944

SCHEMBL4506944

O=Cc1ccc(OCc2ccc(F)cc2Cl)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 1/20 0.51
PTGER1 P34995 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
ALOX15 P16050 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 3/20 0.42
DUSP3 P51452 1/20 0.42
PTPN5 P54829 1/20 0.42
PTPN11 Q06124 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3267969 0.87 ALDH1A1 (0.47) ALDH1A1PTGER1CYP1A2POLBMEN1
SCHEMBL3267315 0.84 HPGD (0.49) ALDH1A1SMN1; SMN2LMNAHTTNPSR1
SCHEMBL3269606 0.79 SMN1; SMN2 (0.47) ALDH1A1SMN1; SMN2LMNAHTTL3MBTL1
SCHEMBL3268166 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2LMNAHTTNPSR1
SCHEMBL3271842 0.78 MAOB (0.52) ALDH1A1SMN1; SMN2LMNACYP1A2CYP3A4
SCHEMBL2650190 0.78 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2LMNAHTTCYP1A2
SCHEMBL3267168 0.78 MRGPRX4 (0.43) SMN1; SMN2HTTHSD17B10L3MBTL1KMT2A
SCHEMBL8371564 0.73 POLB (0.54) ALDH1A1SMN1; SMN2HTTPTGER1CYP1A2
SCHEMBL2664414 0.73 KMT2A (0.49) ALDH1A1SMN1; SMN2LMNAHTTCYP1A2
SCHEMBL3272664 0.73 ENPP2 (0.52) ALDH1A1SMN1; SMN2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 ALDH1A1 381/4885SMN1; SMN2 3541/4885LMNA 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.